Alnajjar Sarhad, Gallup Jack, Ackermann Mark
Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Lambcure LLC, Corvallis, OR, USA.
Methods Mol Biol. 2025;2948:305-322. doi: 10.1007/978-1-0716-4666-3_20.
Respiratory syncytial virus (RSV) is one of the leading causes of lower respiratory tract infections in infants and older adults. There are several animal models to study RSV infection and test the efficacy of antiviral compounds and vaccines. The lamb model has some advantageous features that contribute to it being one of the best animal models of RSV due to the similarity in size, biology, immune responses, and cellular/structural composition of the respiratory system to infants, the susceptibility to human RSV, and the possibility to investigate multiple approaches and experimental designs. Thus, the lamb model is considered and used as a preclinical model to evaluate the effectiveness and characterize the dosing and mechanisms of newly developed antiviral compounds before they move to human clinical trials. In this chapter, the detailed protocol for the lamb model of RSV infection is explained, including all the assays used to evaluate the severity of infection.
呼吸道合胞病毒(RSV)是婴幼儿和老年人下呼吸道感染的主要病因之一。有多种动物模型可用于研究RSV感染并测试抗病毒化合物和疫苗的疗效。羔羊模型具有一些优势特征,由于其在大小、生物学特性、免疫反应以及呼吸系统的细胞/结构组成方面与婴儿相似,对人RSV易感,并且有可能研究多种方法和实验设计,使其成为RSV的最佳动物模型之一。因此,在新开发的抗病毒化合物进入人体临床试验之前,羔羊模型被视为并用作临床前模型来评估其有效性,并确定给药剂量和作用机制。在本章中,将解释RSV感染羔羊模型的详细方案,包括用于评估感染严重程度的所有检测方法。